Ahpra’s September 2026 guidance on off-label, unapproved and compounded medicines, the TGA’s peptide focus and what clinics must check.
A year after the higher risk non-surgical cosmetic advertising guidelines took effect: what they require, what’s happened since and where clinics still slip up.
The TGA consulted from 9 July to 3 September 2026 on targeted Code changes. These are proposals only, and no outcome had been published.
June 2026 TGA guidance shows how business names, booking systems, telehealth, price lists and influencers can unlawfully advertise prescription medicines.
The TGA’s 7 April 2026 rewrite explains when health content becomes advertising. Educational blogs and posts can still be caught.
A plain-English guide to the AHPRA advertising rules: what they cover, what section 133 prohibits, and every key change since 2020, by date.
The TGA’s compliance principles for 2026 and 2027 name cosmetic procedures, weight loss and medicinal cannabis as focus areas. Here is what that means.
The TGA’s 5 November 2025 social media update covers hashtags, reposts, influencers, comments, AI content and historical posts.
From 2 September 2025 new Ahpra rules cover advertising and performing injectables, fillers, laser and other non-surgical cosmetic procedures.
From 1 October 2024 pharmacists can no longer compound GLP-1 RA medicines for supply. What changed and the TGA weight-loss advertising actions.